Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1962 6
1963 2
1964 4
1965 3
1966 1
1967 2
1968 1
1969 5
1970 2
1971 9
1972 10
1973 5
1974 8
1975 5
1976 4
1977 5
1978 6
1979 6
1980 6
1981 14
1982 10
1983 14
1984 12
1985 16
1986 23
1987 19
1988 20
1989 15
1990 17
1991 12
1992 32
1993 20
1994 31
1995 23
1996 33
1997 36
1998 47
1999 37
2000 43
2001 42
2002 53
2003 46
2004 45
2005 36
2006 26
2007 27
2008 30
2009 40
2010 46
2011 48
2012 56
2013 55
2014 62
2015 59
2016 77
2017 93
2018 76
2019 83
2020 120
2021 148
2022 163
2023 132
2024 160
2025 155

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,183 results

Results by year

Filters applied: . Clear all
Page 1
Adolescent Health Promotion Interventions Using Well-Care Visits and a Smartphone Cognitive Behavioral Therapy App: Randomized Controlled Trial.
Nagamitsu S, Kanie A, Sakashita K, Sakuta R, Okada A, Matsuura K, Ito M, Katayanagi A, Katayama T, Otani R, Kitajima T, Matsubara N, Inoue T, Tanaka C, Fujii C, Shigeyasu Y, Ishii R, Sakai S, Matsuoka M, Kakuma T, Yamashita Y, Horikoshi M. Nagamitsu S, et al. Among authors: okada a. JMIR Mhealth Uhealth. 2022 May 23;10(5):e34154. doi: 10.2196/34154. JMIR Mhealth Uhealth. 2022. PMID: 35604760 Free PMC article. Clinical Trial.
Association of SGLT2 inhibitors with incident cancer.
Suzuki Y, Kaneko H, Okada A, Ko T, Jimba T, Fujiu K, Takeda N, Morita H, Komuro J, Ieda M, Node K, Komuro I, Yasunaga H, Takeda N. Suzuki Y, et al. Among authors: okada a. Diabetes Metab. 2024 Nov;50(6):101585. doi: 10.1016/j.diabet.2024.101585. Epub 2024 Oct 24. Diabetes Metab. 2024. PMID: 39455021
COVID Vaccine-Associated Uveitis.
Habot-Wilner Z, Neri P, Okada AA, Agrawal R, Xin Le N, Cohen S, Fischer N, Kilmartin F, Coman A, Kilmartin D. Habot-Wilner Z, et al. Among authors: okada aa. Ocul Immunol Inflamm. 2023 Aug;31(6):1198-1205. doi: 10.1080/09273948.2023.2200858. Epub 2023 May 5. Ocul Immunol Inflamm. 2023. PMID: 37145198 Review.
Author's reply.
Isogai T, Morita K, Okada A, Yasunaga H. Isogai T, et al. Among authors: okada a. J Cardiol. 2025 Aug;86(2):217-218. doi: 10.1016/j.jjcc.2025.04.011. Epub 2025 May 1. J Cardiol. 2025. PMID: 40316166 No abstract available.
Authors' reply.
Isogai T, Morita K, Okada A, Yasunaga H. Isogai T, et al. Among authors: okada a. J Cardiol. 2025 Jul 17:S0914-5087(25)00188-1. doi: 10.1016/j.jjcc.2025.07.004. Online ahead of print. J Cardiol. 2025. PMID: 40683558 No abstract available.
Genetic Risk of Primary Aldosteronism and Its Contribution to Hypertension: A Cross-Ancestry Meta-Analysis of Genome-Wide Association Studies.
Naito T, Inoue K, Sonehara K, Baba R, Kodama T, Otagaki Y, Okada A, Itcho K, Kobuke K, Kishimoto S, Yamamoto K; BioBank Japan; Morisaki T, Higashi Y, Hinata N, Arihiro K, Hattori N, Okada Y, Oki K. Naito T, et al. Among authors: okada a. Circulation. 2023 Apr 4;147(14):1097-1109. doi: 10.1161/CIRCULATIONAHA.122.062349. Epub 2023 Feb 21. Circulation. 2023. PMID: 36802911 Free PMC article.
Influenza A Virus Infection in Domestic Ferrets.
Kuroda Y, Okada A, Shimoda H, Miwa Y, Watamori A, Ishida H, Murakami S, Takada A, Horimoto T, Maeda K. Kuroda Y, et al. Among authors: okada a. Jpn J Infect Dis. 2022 May 24;75(3):325-327. doi: 10.7883/yoken.JJID.2021.745. Epub 2021 Nov 30. Jpn J Infect Dis. 2022. PMID: 34853194 Free article.
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration.
Kataoka K, Itagaki K, Hashiya N, Wakugawa S, Tanaka K, Nakayama M, Yamamoto A, Mukai R, Honjyo J, Maruko I, Kawai M, Miyara Y, Terao N, Wakatsuki Y, Onoe H, Mori R, Koizumi H, Sekiryu T, Iida T, Okada AA; for Japan AMD Research Consortium (JARC). Kataoka K, et al. Among authors: okada aa. Graefes Arch Clin Exp Ophthalmol. 2024 Jan;262(1):43-51. doi: 10.1007/s00417-023-06222-x. Epub 2023 Sep 5. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37668741
2,183 results